Advanced Biomedical Technologies

Advanced Biomedical Technologies FCF Growth

The Year-over-Year Free Cash Flow Growth of Advanced Biomedical Technologies (ABMT) as of Oct 27, 2026 is 180.94 %. In the previous year, Year-over-Year Free Cash Flow Growth was 15.13 % — a change of 1,095.75% (higher).

FCF Growth

180.94 %

YoY

1,095.75%

Last updated:

Year-over-Year Free Cash Flow Growth of Advanced Biomedical Technologies is 2020 180.94 % . Year-over-Year Free Cash Flow Growth of Advanced Biomedical Technologies was 2019 15.13 % . It decreases by 1,095.75% higher compared to the previous year.

The Advanced Biomedical Technologies FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2015
-15.04 USD
Jan 1, 2016
56.21 USD
Jan 1, 2017
-49.49 USD
Jan 1, 2018
-60.66 USD
Jan 1, 2019
15.13 USD
Jan 1, 2020
180.94 USD
The Advanced Biomedical Technologies FCF Growth history
YEARFCF GrowthYoY
180.94 %+1,095.75%
15.13 %-124.95%
-60.66 %+22.57%
-49.49 %-188.05%
56.21 %-473.66%
-15.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Advanced Biomedical Technologies Stock analysis

What does Advanced Biomedical Technologies do? Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation. Advanced Biomedical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Biomedical Technologies stock

Year-over-Year Free Cash Flow Growth of Advanced Biomedical Technologies is 180.94 % in 2020.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Advanced Biomedical Technologies since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Advanced Biomedical Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Advanced Biomedical Technologies

All Key Metrics — Advanced Biomedical Technologies